Finckenstein Friedrich Graf
CIK: 0001782981
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
IOVANCE BIOTHERAPEUTICS, INC.
Discretionary Trading P&L
Holdings
Transaction History (30 total)
- Jun 5, 2026IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Tax Payment(F)Direct4K shares at avg. $4.23$17K - Jun 5, 2026IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Exercise(M)Direct7.8K shares- - Jun 1, 2026IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Exercise(M)Direct8.8K shares- - Jun 1, 2026IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Tax Payment(F)Direct4.5K shares at avg. $3.96$18K - Mar 9, 2026IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Award(A)DirectRestricted Stock Units
58.8K shares- - Mar 5, 2026IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Tax Payment(F)Direct16.5K shares at avg. $4.58$76K - Mar 5, 2026IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Exercise(M)Direct31.2K shares- - Mar 2, 2026IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Tax Payment(F)Direct7.1K shares at avg. $3.79$27K - Mar 2, 2026IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Exercise(M)Direct12.7K shares- - Dec 2, 2025IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Exercise(M)Direct3.9K shares- - Dec 2, 2025IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Tax Payment(F)Direct2K shares at avg. $2.14$4K - Dec 1, 2025IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Exercise(M)Direct8.8K shares- - Dec 1, 2025IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Tax Payment(F)Direct4.5K shares at avg. $2.23$10K - Sep 2, 2025IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Exercise(M)Direct12.7K shares- - Sep 2, 2025IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Tax Payment(F)Direct6.4K shares at avg. $2.19$14K - Jun 2, 2025IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Tax Payment(F)Direct6.4K shares at avg. $1.76$11K - Jun 2, 2025IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Exercise(M)Direct12.7K shares- - Mar 5, 2025IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Award(A)DirectRestricted Stock Units
93.8K shares- - Mar 3, 2025IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Exercise(M)Direct62.5K shares- - Mar 3, 2025IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Tax Payment(F)Direct33.5K shares at avg. $4.04$135K - Jan 14, 2025IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Exercise(M)Direct2.8K shares- - Jan 14, 2025IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Tax Payment(F)Direct1.6K shares at avg. $5.89$9K - Dec 2, 2024IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Exercise(M)Direct3.9K shares- - Dec 2, 2024IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Tax Payment(F)Direct2K shares at avg. $9.07$18K - Oct 14, 2024IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Exercise(M)Direct2.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 5, 2026 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Tax Payment(F) | 3,976 | $4.23 | $16,818 | Direct |
| Jun 5, 2026 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Exercise(M) | 7,813 | - | $0 | Direct |
| Jun 1, 2026 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Exercise(M) | 8,790 | - | $0 | Direct |
| Jun 1, 2026 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Tax Payment(F) | 4,473 | $3.96 | $17,713 | Direct |
| Mar 9, 2026 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Award(A) Restricted Stock Units | 58,750 | - | - | Direct |
| Mar 5, 2026 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Tax Payment(F) | 16,520 | $4.58 | $75,662 | Direct |
| Mar 5, 2026 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Exercise(M) | 31,246 | - | $0 | Direct |
| Mar 2, 2026 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Tax Payment(F) | 7,122 | $3.79 | $26,992 | Direct |
| Mar 2, 2026 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Exercise(M) | 12,697 | - | $0 | Direct |
| Dec 2, 2025 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Exercise(M) | 3,906 | - | - | Direct |
| Dec 2, 2025 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Tax Payment(F) | 1,984 | $2.14 | $4,246 | Direct |
| Dec 1, 2025 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Exercise(M) | 8,789 | - | - | Direct |
| Dec 1, 2025 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Tax Payment(F) | 4,464 | $2.23 | $9,955 | Direct |
| Sep 2, 2025 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Exercise(M) | 12,697 | - | - | Direct |
| Sep 2, 2025 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Tax Payment(F) | 6,448 | $2.19 | $14,121 | Direct |
| Jun 2, 2025 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Tax Payment(F) | 6,448 | $1.76 | $11,348 | Direct |
| Jun 2, 2025 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Exercise(M) | 12,695 | - | - | Direct |
| Mar 5, 2025 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Award(A) Restricted Stock Units | 93,750 | - | - | Direct |
| Mar 3, 2025 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Exercise(M) | 62,497 | - | - | Direct |
| Mar 3, 2025 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Tax Payment(F) | 33,470 | $4.04 | $135,219 | Direct |
| Jan 14, 2025 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Exercise(M) | 2,813 | - | $0 | Direct |
| Jan 14, 2025 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Tax Payment(F) | 1,578 | $5.89 | $9,294 | Direct |
| Dec 2, 2024 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Exercise(M) | 3,906 | - | $0 | Direct |
| Dec 2, 2024 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Tax Payment(F) | 1,982 | $9.07 | $17,977 | Direct |
| Oct 14, 2024 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Exercise(M) | 2,813 | - | $0 | Direct |
1-25 of 30 transactions
About GRAF FINCKENSTEIN FRIEDRICH
GRAF FINCKENSTEIN FRIEDRICH (SEC CIK 0001782981) files insider reports with the SEC as Chief Medical Officer of IOVANCE BIOTHERAPEUTICS, INC. (IOVA).
Signal8 holds 14 ownership filings by GRAF FINCKENSTEIN FRIEDRICH, all Form 4s, filed between Sep 5, 2024 and Jun 9, 2026. Those filings report 30 transactions, from Sep 3, 2024 to Jun 5, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on GRAF FINCKENSTEIN FRIEDRICH's filings is in SAN CARLOS, CA.
Recent filings by GRAF FINCKENSTEIN FRIEDRICH
- Jun 5, 2026: Tax withholding of IOVA shares (Form 4, code F).
- Jun 5, 2026: Option exercise of IOVA shares (Form 4, code M).
- Jun 1, 2026: Option exercise of IOVA shares (Form 4, code M).
- Jun 1, 2026: Tax withholding of IOVA shares (Form 4, code F).
- Mar 9, 2026: Grant or award of IOVA derivative securities (Form 4, code A).
Other insiders filing for IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
- Berkowitz Noah, Chief Medical Officer
- Vogt Frederick G, Interim CEO & General Counsel
- BILINSKY IGOR, Chief Operating Officer
- Puri Raj K., Chief Regulatory Officer
- Kirby Daniel Gordon, Chief Commercial Officer
- Roche Corleen M., Chief Financial Officer